Canada · Delayed Price · Currency is CAD PharmaTher Holdings Company Description
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.
The company’s product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson’s disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management.
It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX wearable pump for the maintenance of general anesthesia for diagnostic, surgical procedures and pain indications.
In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases.
Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; with the University of Arizona for the development and commercialization of ketamine in the treatment of Parkinson’s disease; as well as holds a patent and know-how license agreement with The Queen’s University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology.
The company was incorporated in 2019 and is headquartered in Toronto, Canada.
| Country | Canada |
| Founded | 2019 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Fabio Chianelli |
Contact Details
Address: 82 Richmond Street East Toronto, Ontario M5C 1P1 Canada | |
| Phone | 888-846-3171 |
| Website | pharmather.com |
Stock Details
| Ticker Symbol | PHRM |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | June - May |
| Reporting Currency | CAD |
| ISIN Number | CA71716H1082 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Fabio Chianelli | Founder, Chairman and Chief Executive Officer |
| Carmelo Marrelli ACIS, B.Comm., C.A., C.P.A., CGA, CPA | Chief Financial Officer |
| Andrew Todd | Corporate Secretary |